|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,370.00 JPY | +0.30% |
|
+1.89% | -6.21% |
| 05-14 | Fda approves new dosing option for Crysvita® (burosumab-twza) in adults with XLH | RE |
| 05-07 | Kyowa Kirin's Profit Surges 95% in Q1 | MT |
| Capitalization | 1,241B 7.82B 6.73B 6.15B 5.87B 10.76B 750B 10.94B 73.81B 28.56B 356B 29.34B 28.71B | P/E ratio 2026 * |
15.2x | P/E ratio 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise value | 1,001B 6.31B 5.43B 4.97B 4.74B 8.69B 606B 8.83B 59.57B 23.05B 287B 23.69B 23.18B | EV / Sales 2026 * |
1.92x | EV / Sales 2027 * | 1.81x |
| Free-Float |
44.6% | Yield 2026 * |
2.89% | Yield 2027 * | 3.05% |
| 1 day | +0.30% | ||
| 1 week | +1.89% | ||
| Current month | +0.34% | ||
| 1 month | -6.06% | ||
| 3 months | -8.56% | ||
| 6 months | -4.90% | ||
| Current year | -6.21% |
| 1 week | 2,304.5 |  | 2,416.5 |
| 1 month | 2,154.5 | | 2,500 |
| Current year | 2,109 | | 2,912 |
| 1 year | 2,109 | | 2,912 |
| 3 years | 2,025 | | 3,350 |
| 5 years | 2,025 | | 4,240 |
| 10 years | 1,412 | | 4,240 |
| Manager | Title | Age | Since |
|---|---|---|---|
Abdul Mullick
CEO | Chief Executive Officer | - | 2026-02-28 |
| Director of Finance/CFO | - | 1986-03-31 | |
| Chief Tech/Sci/R&D Officer | 64 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Masashi Miyamoto
CHM | Chairman | 66 | 2025-02-28 |
Takashi Oyamada
BRD | Director/Board Member | 70 | 2021-02-28 |
Yoshihisa Suzuki
BRD | Director/Board Member | 70 | 2022-02-28 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +22.86% | 0.36% | 85,612 M€ | |
| +12.23% | 0.23% | 77 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.30% | +1.89% | +7.19% | -13.97% | 7.82B | |
| -2.82% | +3.99% | +2.44% | -27.58% | 59.29B | |
| -3.02% | +4.68% | +29.03% | +101.56% | 7.96B | |
| -5.66% | -2.82% | +6.50% | +36.63% | 5.05B | |
| -3.80% | -0.69% | -19.02% | +57.32% | 4.26B | |
| +0.90% | -1.73% | +3.14% | -26.14% | 3.13B | |
| -3.46% | -4.08% | +47.86% | +40.59% | 2.87B | |
| +1.12% | -4.51% | +19.00% | +4.62% | 2.43B | |
| -2.27% | -3.51% | +72.97% | +32.05% | 1.97B | |
| +1.10% | +4.67% | +49.21% | +10.39% | 1.91B | |
| Average | -1.76% | -0.91% | +21.83% | +21.55% | 9.67B | |
| Weighted average by Cap. | -2.49% | +2.44% | +8.43% | -3.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 521B 3.28B 2.83B 2.58B 2.46B 4.52B 315B 4.59B 30.99B 11.99B 150B 12.32B 12.06B | 536B 3.38B 2.91B 2.66B 2.53B 4.65B 324B 4.72B 31.87B 12.33B 154B 12.67B 12.4B |
| Net income | 77.01B 485M 418M 382M 364M 668M 46.56B 679M 4.58B 1.77B 22.1B 1.82B 1.78B | 84.14B 530M 456M 417M 398M 730M 50.88B 742M 5.01B 1.94B 24.15B 1.99B 1.95B |
| Net Debt | -239B -1.51B -1.3B -1.19B -1.13B -2.07B -145B -2.11B -14.23B -5.51B -68.66B -5.66B -5.54B | -270B -1.7B -1.47B -1.34B -1.28B -2.35B -164B -2.38B -16.09B -6.23B -77.63B -6.4B -6.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 2,370.00 ¥ | +0.30% | 1,113,400 |
| 26-05-14 | 2,363.00 ¥ | +0.23% | 1,016,900 |
| 26-05-13 | 2,357.50 ¥ | +1.12% | 1,305,200 |
| 26-05-12 | 2,331.50 ¥ | -2.22% | 1,385,000 |
| 26-05-11 | 2,384.50 ¥ | +2.52% | 1,786,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4151 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition